Patients with chronic liver disease are at higher risk of hepatitis B (HB) virus infection before and after liver transplantation, and they commonly have a suboptimal immune response to HB vaccines. In this randomized trial, we compared the immunogenicity of primary vaccination with 2 doses of an ex
✦ LIBER ✦
Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients
✍ Scribed by CHIEW TONG, NORELLA KONG; BERAN, JIRI; KEE, SWEE ANN; MIGUEL, JOSE LUIS; SÁNCHEZ, CARMEN; BAYAS, JOSE MARIA; VILELLA, A; DE JUANES, J R; ARRAZOLA, P; CALBO-TORRECILLAS, FRANCISCO; DE NOVALES, EDUARDO LÓPEZ; HAMTIAUX, VIRGINIE; LIEVENS, MARC; STOFFEL, MICHEL
- Book ID
- 109067457
- Publisher
- Nature Publishing Group
- Year
- 2005
- Tongue
- English
- Weight
- 82 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0085-2538
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Immunogenicity and safety of an experime
✍
Frederik Nevens; Jane N. Zuckerman; Andrew K. Burroughs; Maria-Christina Jung; J
📂
Article
📅
2006
🏛
John Wiley and Sons
🌐
English
⚖ 166 KB
AM3 (Inmunoferón®) as an adjuvant to h
✍
Pérez-GarcÃa, Rafael; Pérez-GarcÃa, Alfonso; Verbeelen, Dierik; Bernstein, E
📂
Article
📅
2002
🏛
Nature Publishing Group
🌐
English
⚖ 157 KB
Recombinant γ-interferon as adjuvant to
✍
Juan Antonio Quiroga; Inmaculada Castillo; Juan Carlos Porres; Santos Casado; Fe
📂
Article
📅
1990
🏛
John Wiley and Sons
🌐
English
⚖ 316 KB
Long-term immunogenicity and safety of a
✍
PIETRO DENTICO; NICOLA CIAVARELLA; FRANCESCO A. SCARAGGI; MARIO SCHIAVONI; ANNA
📂
Article
📅
1996
🏛
John Wiley and Sons
🌐
English
⚖ 318 KB
Peripheral blood dendritic cells and GM-
✍
VERKADE, MARTIJN A; VAN DE WETERING, JACQUELINE; KLEPPER, MARISKA; VAESSEN, LEON
📂
Article
📅
2004
🏛
Nature Publishing Group
🌐
English
⚖ 110 KB
Safety and immunogenicity of hepatitis A
✍
Emmet B. Keeffe; Sten Iwarson; Brian J. McMahon; Karen L. Lindsay; Raymond S. Ko
📂
Article
📅
1998
🏛
John Wiley and Sons
🌐
English
⚖ 74 KB
👁 2 views
Acute hepatitis A superimposed on chronic liver disease (CLD) has been associated with severe or fulminant hepatitis. An open, multicenter study was performed to compare the safety and immunogenicity of an inactivated hepatitis A vaccine in patients with CLD with that in healthy subjects. A secondar